Danaher Corporation (DHR): Officer sold ~$1.99M

~$1.99M

Approx. value · 8,370 sh @ $238.00

15K

Holds after · shares reported

Traded

Nov 25, 2024

Filed

Nov 27, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 25, 2024 · this disclosureInsiderOfficer sold ~$1.99M of DHR shares in the open market

What came next

1. Nov 26, 2024InsiderOfficer sold ~$6.23M of DHR shares in the open market
2. Jan 10, 2025FDAFDA device clearance: Xpert Xpress CoV-2/Flu/RSV plus
3. Jan 10, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software.
4. Jan 14, 2025FDAFDA device clearance: ABL90 FLEX PLUS System
5. Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
6. Jan 30, 2025FDARecall: Brand Name: Leica Biosystems Cryostats Product Name: CM1950 Model/Catalog Number: 1491950C4US Software Version: firmware V3.01
7. Jan 30, 2025InsiderOfficer sold ~$1.28M of DHR shares in the open market
8. Feb 3, 2025FDARecall: Access Erythropoietin (EPO), Catalog Number - A16364 a glycoprotein (~30,400 Daltons) produced primarily by the kidney, is the principal factor regulating red…
9. Feb 5, 2025FDARecall: Access 2 Immunoassay Analyzer, Catalog Number 81600N
10. Feb 5, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137.
11. Feb 6, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, with Component PCB, TSI/RSI firmware C29278
12. Feb 7, 2025InsiderDirector sold ~$114K of DHR shares in the open market
13. Feb 13, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
14. Feb 21, 2025FDAFDA device clearance: Xpert® FII & FV
15. Feb 26, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 The Beckman Coulter DxC 500 AU Clinical Chem…
16. Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
17. Feb 27, 2025FDARecall: Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850
18. Mar 5, 2025FDAFDA device clearance: Access Cortisol; DxC 500i Clinical Analyzer
19. Mar 17, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 Software versions: V1.3, V1.4, V1.4.1, V1.4.…
20. Mar 20, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065. The Beckman Coulter DxC 500 AU Clinical Che…

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Daniel Raskas, SVP - Corporate Development

• SEC Form 4 at Danaher Corporation (DHR)Nov 27, 2024

The full history of Daniel Raskas, SVP - Corporate Development is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Danaher Corporation

• SEC Form 144Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026

Everything OQRO holds on this company is on its DHR page.